GlassScriptPhysician profile
Eric Michael Sickinger
NPI 1215367792
$11,538.45
in general payments reported to CMS, 2019-2025
27 companies · $1,618 in 2025
The $1,618 reported for 2025 was more than what 90% of Neuromusculoskeletal Medicine, Sports Medicine providers received nationally (typical 2025 total: $125).
See the full distribution for Neuromusculoskeletal Medicine, Sports Medicine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,212 · 2020: $1,320 · 2021: $1,672 · 2022: $1,362 · 2023: $1,162 · 2024: $1,194 · 2025: $1,618.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,336 · Food and Beverage: $637.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,336.48 |
| Food and Beverage | $636.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $7,074.27 | 2019-2025 | Procare |
| Arthrex, INC. | $1,948.21 | 2019 | |
| Sportstek Medical, INC | $355.65 | 2019 | |
| Fidia Pharma USA INC. | $322.07 | 2019-2025 | Hymovis, Triluron, Hyalgan |
| Epi Health, LLC | $229.86 | 2021 | |
| Endo Pharmaceuticals INC. | $180.72 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $151.92 | 2022 | |
| Abbott Laboratories | $133.84 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $129.59 | 2021 | |
| Botanix Sb INC | $129.11 | 2025 | Sofdra |
| Bioventus LLC | $122.62 | 2019-2025 | Durolane, Exogen Ultrasound Bone Healing System, Xcell |
| Novo Nordisk INC | $118.63 | 2025 | Wegovy |
| Medtronic Vascular, INC. | $100.42 | 2020 | |
| Galderma Laboratories, L.P. | $82.71 | 2025 | Nemluvio |
| Conformis, INC. | $78.94 | 2019 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biofrontera INC. | $66.14 | 2019-2025 | Xepi, Bf-Rhodoled, Ameluz |
| Maxx Orthopedics, INC. | $63.63 | 2019 | |
| Pacira Therapeutics, INC. | $49.44 | 2019-2021 | |
| Abbvie INC. | $33.69 | 2025 | |
| Empire Medical, INC | $31.26 | 2022 | |
| Spinesmith Holdings, LLC | $25.63 | 2019 | |
| Alexion Pharmaceuticals, INC. | $24.13 | 2025 | Ultomiris |
| Pacira Pharmaceuticals Incorporated | $23.12 | 2023 | Exparel, Zilretta, Iovera |
| Ferring Pharmaceuticals INC. | $16.58 | 2019 | |
| Orthogenrx INC. | $15.94 | 2020 | |
| Depuy Synthes Sales INC. | $15.31 | 2025 | Monovisc, Orthovisc |
| Tenex Health INC. | $15.02 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Sickinger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.